List of Tables
    Table 1. Cystic Fibrosis Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cystic Fibrosis Therapeutics Market Trends
    Table 3. Cystic Fibrosis Therapeutics Market Drivers
    Table 4. Cystic Fibrosis Therapeutics Market Challenges
    Table 5. Cystic Fibrosis Therapeutics Market Restraints
    Table 6. Global Cystic Fibrosis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cystic Fibrosis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cystic Fibrosis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cystic Fibrosis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cystic Fibrosis Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cystic Fibrosis Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cystic Fibrosis Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Cystic Fibrosis Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cystic Fibrosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2021)
    Table 15. Top Players of Cystic Fibrosis Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cystic Fibrosis Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cystic Fibrosis Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cystic Fibrosis Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cystic Fibrosis Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cystic Fibrosis Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cystic Fibrosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cystic Fibrosis Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cystic Fibrosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cystic Fibrosis Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cystic Fibrosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cystic Fibrosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cystic Fibrosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Vertex Pharmaceuticals Company Details
    Table 31. Vertex Pharmaceuticals Business Overview
    Table 32. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product
    Table 33. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Vertex Pharmaceuticals Recent Development
    Table 35. F. Hoffmann-La Roche Company Details
    Table 36. F. Hoffmann-La Roche Business Overview
    Table 37. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product
    Table 38. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. F. Hoffmann-La Roche Recent Development
    Table 40. AbbVie Company Details
    Table 41. AbbVie Business Overview
    Table 42. AbbVie Cystic Fibrosis Therapeutics Product
    Table 43. AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. AbbVie Recent Development
    Table 45. Gilead Sciences Company Details
    Table 46. Gilead Sciences Business Overview
    Table 47. Gilead Sciences Cystic Fibrosis Therapeutics Product
    Table 48. Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Gilead Sciences Recent Development
    Table 50. Novartis Company Details
    Table 51. Novartis Business Overview
    Table 52. Novartis Cystic Fibrosis Therapeutics Product
    Table 53. Novartis Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Novartis Recent Development
    Table 55. AstraZeneca Company Details
    Table 56. AstraZeneca Business Overview
    Table 57. AstraZeneca Cystic Fibrosis Therapeutics Product
    Table 58. AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. AstraZeneca Recent Development
    Table 60. Bayer Company Details
    Table 61. Bayer Business Overview
    Table 62. Bayer Cystic Fibrosis Therapeutics Product
    Table 63. Bayer Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Bayer Recent Development
    Table 65. Celtaxsys Company Details
    Table 66. Celtaxsys Business Overview
    Table 67. Celtaxsys Cystic Fibrosis Therapeutics Product
    Table 68. Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. Celtaxsys Recent Development
    Table 70. Pharmaxis Company Details
    Table 71. Pharmaxis Business Overview
    Table 72. Pharmaxis Cystic Fibrosis Therapeutics Product
    Table 73. Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. Pharmaxis Recent Development
    Table 75. ProQR Therapeutics Company Details
    Table 76. ProQR Therapeutics Business Overview
    Table 77. ProQR Therapeutics Cystic Fibrosis Therapeutics Product
    Table 78. ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 79. ProQR Therapeutics Recent Development
    Table 80. PTC Therapeutics Company Details
    Table 81. PTC Therapeutics Business Overview
    Table 82. PTC Therapeutics Cystic Fibrosis Therapeutics Product
    Table 83. PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 84. PTC Therapeutics Recent Development
    Table 85. Alcresta Therapeutics Company Details
    Table 86. Alcresta Therapeutics Business Overview
    Table 87. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product
    Table 88. Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 89. Alcresta Therapeutics Recent Development
    Table 90. Insmed Incorporated Company Details
    Table 91. Insmed Incorporated Business Overview
    Table 92. Insmed Incorporated Cystic Fibrosis Therapeutics Product
    Table 93. Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 94. Insmed Incorporated Recent Development
    Table 95. Savara Company Details
    Table 96. Savara Business Overview
    Table 97. Savara Cystic Fibrosis Therapeutics Product
    Table 98. Savara Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 99. Savara Recent Development
    Table 100. Cyclacel Pharmaceuticals Company Details
    Table 101. Cyclacel Pharmaceuticals Business Overview
    Table 102. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product
    Table 103. Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 104. Cyclacel Pharmaceuticals Recent Development
    Table 105. Vectura Company Details
    Table 106. Vectura Business Overview
    Table 107. Vectura Cystic Fibrosis Therapeutics Product
    Table 108. Vectura Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 109. Vectura Recent Development
    Table 110. Allergan Company Details
    Table 111. Allergan Business Overview
    Table 112. Allergan Cystic Fibrosis Therapeutics Product
    Table 113. Allergan Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 114. Allergan Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cystic Fibrosis Therapeutics Product Picture
    Figure 2. Global Cystic Fibrosis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cystic Fibrosis Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cystic Fibrosis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cystic Fibrosis Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cystic Fibrosis Therapeutics Market Share in Global 2017-2028
    Figure 7. Cystic Fibrosis Therapeutics Report Years Considered
    Figure 8. Product Picture of CFTR
    Figure 9. Product Picture of Mucolytics
    Figure 10. Product Picture of PERT
    Figure 11. Product Picture of Anti-infectives
    Figure 12. Product Picture of Bronchodilators
    Figure 13. Global Cystic Fibrosis Therapeutics Market Share by Type in 2022 & 2028
    Figure 14. Global Cystic Fibrosis Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Cystic Fibrosis Therapeutics Market Share by Type (2017-2028)
    Figure 16. United States Cystic Fibrosis Therapeutics Market Share by Type in 2022 & 2028
    Figure 17. United States Cystic Fibrosis Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Cystic Fibrosis Therapeutics Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Clinics
    Figure 21. Global Cystic Fibrosis Therapeutics Market Share by Application in 2022 & 2028
    Figure 22. Global Cystic Fibrosis Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Cystic Fibrosis Therapeutics Market Share by Application (2017-2028)
    Figure 24. United States Cystic Fibrosis Therapeutics Market Share by Application in 2022 & 2028
    Figure 25. United States Cystic Fibrosis Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Cystic Fibrosis Therapeutics Market Share by Application (2017-2028)
    Figure 27. North America Cystic Fibrosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Cystic Fibrosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Cystic Fibrosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Cystic Fibrosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Cystic Fibrosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 56. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 57. AbbVie Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 58. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 60. AstraZeneca Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 61. Bayer Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 62. Celtaxsys Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 63. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 64. ProQR Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 65. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 66. Alcresta Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 67. Insmed Incorporated Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 68. Savara Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 69. Cyclacel Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 70. Vectura Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 71. Allergan Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed